Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04332861 · ClinicalTrials.gov registry record
Evaluation of Infection in Obstructing Urolithiasis
A clinical trial of Sepsis and Infection, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 477
- Enrollment target
- 2
- Study locations
NCT04332861 is a study of Sepsis and Infection that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 477 participants, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04332861, a study of Sepsis and Infection, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 477 participants
- Enrollment target
- 2
- Study locations
Study Summary
Obstructing urolithiasis can be life-threatening in the setting of urinary tract infection. The purpose of this study is to identify and validate risk factors and markers for the presence of infection and development of sepsis among patients with obstructing urolithiasis.
Conditions Studied
Interventions
- OTHER Initial clinical and laboratory evaluation
Study Locations (2)
Texas
- Parkland Memorial Hospital - Dallas
- UT Southwestern Medical Center Clements University Hospital - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2020-07-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04332861
The ClinicalTrials.gov registry entry for NCT04332861 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (93% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Initial clinical and laboratory evaluation is the first listed.
NCT04332861 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04332861 about?
NCT04332861 is a clinical study titled "Evaluation of Infection in Obstructing Urolithiasis". Obstructing urolithiasis can be life-threatening in the setting of urinary tract infection. The purpose of this study is to identify and validate risk factors and markers for the presence of infection and development of sepsis among patients with obstructing urolithiasis.
What is the current status of trial NCT04332861?
This trial is currently completed. The enrollment target is 477 participants. The study started on 2019-09-03. Estimated completion is 2020-07-28.
What conditions does trial NCT04332861 study?
This clinical trial studies the following conditions: Sepsis, Infection, Kidney Stone, Kidney Calculi, Urinary Tract Obstruction.
What interventions are being tested in trial NCT04332861?
The interventions under investigation include: Initial clinical and laboratory evaluation (OTHER).
Who is sponsoring clinical trial NCT04332861?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04332861 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.